Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Commentary : Patient’s Voice
Corrigendum
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letter to the Editor – Authors’ reply
Letters to Editor
Literature Review
Nephrology in India
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Commentary : Patient’s Voice
Corrigendum
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letter to the Editor – Authors’ reply
Letters to Editor
Literature Review
Nephrology in India
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
View/Download PDF

Translate this page into:

Editorial
30 (
3
); 141-142
doi:
10.4103/ijn.IJN_228_20

Covid-19: Why the Kidney Care is so much Affected?

Department of Nephrology, AIIMS, New Delhi, India
Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

Address for correspondence: Dr. Sanjay K. Agarwal, Department of Nephrology, AIIMS, New Delhi, India. E-mail: skagarwalnephro@gmail.com

Licence

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.

In December 2019, a series of cases of pneumonia of unknown origin were reported in Wuhan, the capital city of Hubei province in China. The causative virus was isolated and characterized in January 2020.[1] On January 12, 2020, the World Health Organization (WHO) named the virus as the 2019 novel coronavirus (2019-nCoV). On January 30, 2020, the WHO issued a public health emergency of international concern (PHEIC) and on February 11, 2020, the WHO formally named the disease caused by the novel coronavirus as coronavirus disease 2019 (COVID-19). The International Committee on Taxonomy of Viruses classified and renamed 2019-nCoV as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On March 11, 2020, the WHO labelled the global spread of COVID-19 as a pandemic.

Though to start with the COVID-19 primarily had respiratory symptoms as presenting features, soon it was realized that it is a systemic disease involving other organs of the body also like heart, nervous system, liver, blood vessels and kidney. Later it became clear that some of the patients may present with non-respiratory symptoms. Host susceptibility, particularly elderly and peoples with underlying diseases, hypertension, cardiac diseases, bronchial asthma, diabetes, chronic kidney disease (CKD) etc., influence the risk of acquiring and progression of COVID-19.

There are three issues related to kidney diseases and COVID-19.

Firstly, pre-existing kidney diseases, including hypertension, CKD, a glomerular disease requiring immunosuppressive therapy, the patients on dialysis, and with kidney transplants are all immunocompromised patients and risk of getting COVID-19 is not only more but also clinical manifestation may be atypical. Also, the primary aetiology of CKD being diabetes and hypertension make these patients at further risk of severe COVID-19 and poorer outcome.

Secondly, SARS-CoV-2 can also affect the kidney. The mechanism of kidney injury by COVID-19 appears multifactorial, although precisely, remains unknown.[2] The direct viral cytopathic effect on kidney tissue is a postulated mechanism, which is supported by the finding of viral nucleic acid material of CoV in blood and urine in SARS-CoV as well as the patients with COVID-19.[3] The direct effector T-cell-mediated injury and the immune complex-mediated glomerular injury with viral antigen and specific antibody could be another plausible mechanism. The other mechanism could be by inducing sepsis and the cytokine storm theory.[4] The cytokines and other mediators are released after COVID-19 infection leading to sustained inflammatory response leading to hypotension, hypoxia, shock, and target organ injuries. The incidence of AKI with COVID infection reportedly varies from 3% to 9%. A larger prospective study reported the overall incidence of 5.1%.[5] Li et al.[6] found that 34% of the patients had albuminuria on the first day of admission, and 63% developed proteinuria during the hospital stay.

Thirdly, due to various measures taken by local government and policymakers regarding containment of COVID-19, providing kidney care to patients became a significant issue. Lockdown had resulted in difficulty in getting life-saving medicines for CKD, glomerular disease and kidney transplant. Elective surgeries, including elective living-related renal transplant and also elective CAPD catheter insertion, were practically cancelled across the country by the government policy to divert human resources and other facilities in COVID-19 care. Deceased donor transplant, though considered an emergency procedure had also come to halt. Providing haemodialysis became a challenge. Pre-dialysis testing for COVID-19, dialysing in the isolation room, preventing COVID-19 among dialysis patients and staff and non-availability of dialysis consumables, all became challenges and controversies. Panic resulting in the closing of some of the dialysis units temporarily had further increased the problems.

With such a scenario in the country, the Indian Society of Nephrology constituted a COVID-19 Task Force* to address these issues to guide the colleagues in the best way to handle the situation of patients of kidney disease while balancing the ground realities and government policies. Country's leading nephrologists were put on board to write on different issues related to caring of patients of various kidney diseases and those manuscripts have been put in the symposium in the current issue.

We hope that these documents will be useful to the colleagues for better management of the situation and patient care.

References

  1. , , , , , , . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.
    [Google Scholar]
  2. , , , , , . Features, Evaluation and Treatment Coronavirus (COVID-19) [Updated 2020 Mar 08] . StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
    [Google Scholar]
  3. , , , , , , . Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-38.
    [Google Scholar]
  4. , , , , , , . Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67:698-705.
    [Google Scholar]
  5. , , , , , , . Kidney impairment is associated with in-hospital death of COVID-19 patients [e-pub ahead of print] medRxiv 2020021820023242 doi: 101101/2020021820023242
    [Google Scholar]
  6. , , , , , , . Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv doiorg/101101/2020020820021212
    [Google Scholar]

    Fulltext Views
    310

    PDF downloads
    670
    View/Download PDF
    Download Citations
    BibTeX
    RIS
    Show Sections